Performance of the Molecular International Prognostic Scoring System (IPSS-M) in Hypomethylating Agent-Treated Patients with Myelodysplastic Syndromes

被引:0
|
作者
Chien, Kelly S. [1 ]
Urrutia, Samuel [2 ]
Li, Ziyi [3 ]
Kanagal-Shamanna, Rashmi [4 ]
Abdelhakeem, Ahmed [1 ]
Abuasab, Tareq [1 ]
Almanza, Emmanuel [1 ]
Gener-Ricos, Georgina [1 ]
Bataller, Alex [1 ]
Bazinet, Alexandre [1 ]
Montalban-Bravo, Guillermo [1 ]
Short, Nicholas J. [1 ]
Jabbour, Elias [1 ]
Kadia, Tapan M. [1 ]
Ravandi, Farhad [1 ]
Borthakur, Gautam [1 ]
Hammond, Danielle E. [1 ]
Swaminathan, Mahesh [1 ]
Sasaki, Koji [1 ]
Dong, Xiao Qin [1 ]
Pierce, Sherry [1 ]
Kantarjian, Hagop [1 ]
Garcia-Manero, Guillermo [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
关键词
D O I
10.1182/blood-2023-189557
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [1] External validation of the Molecular International Prognostic Scoring System (IPSS-M) for myelodysplastic syndromes
    Chernak, Brian
    Ali, Abdullah
    Jan, Amna
    Mukherjee, Sanjay
    Jurcic, Joseph G.
    Raza, Azra
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Validation of the Molecular International Prognostic Scoring System (IPSS-M) in Patients (Pts) with Myelodysplastic Syndromes/Neoplasms (MDS) Who Were Treated with Hypomethylating Agents (HMA)
    Kewan, Tariq
    Bewersdorf, Jan Philipp
    Blaha, Ondrej
    Stahl, Maximilian
    Ali, Najla Hal
    DeZern, Amy E.
    Sekeres, Mikkael A.
    Carraway, Hetty E.
    Desai, Pinkal
    Griffiths, Elizabeth A.
    Stein, Eytan M.
    Brunner, Andrew M.
    Amaya, Maria L.
    Zeidner, Joshua F.
    Savona, Michael R.
    Stempel, Jessica M.
    Chandhok, Namrata Sonia
    Logothetis, Constantine
    Ramaswamy, Rahul
    Rose, Ameera
    Roboz, Gail J.
    Rolles, Benjamin
    Wang, Eunice S.
    Harris, Amyah C.
    Shallis, Rory M.
    Xie, Zhuoer
    Padron, Eric
    Maciejewski, Jaroslaw P.
    Sallman, David A.
    Della Porta, Matteo Giovanni
    Komrokji, Rami S.
    Zeidan, Amer M.
    BLOOD, 2023, 142
  • [3] Validation of the Molecular International Prognostic Scoring System (IPSS-M) Risk Stratification Model for Myelodysplastic Syndromes
    Aguirre, Luis E.
    Al Ali, Najla
    Ball, Somedeb
    Singh, Avani M.
    Jain, Akriti G.
    Chan, Onyee
    Schwabkey, Zaker, I
    Tinsley-Vance, Sara M.
    Kuykendall, Andrew
    Sweet, Kendra
    Lancet, Jeffrey E.
    Padron, Eric
    Sallman, David A.
    Komrokji, Rami S.
    BLOOD, 2022, 140 : 1125 - 1127
  • [4] Real-World Validation of Molecular International Prognostic Scoring System (IPSS-M) for Myelodysplastic Syndromes
    Sauta, Elisabetta
    Robin, Marie
    Bersanelli, Matteo
    Travaglino, Erica
    Meggendorfer, Manja
    Zhao, Lin-Pierre
    Berrocal, Juan Carlos Caballero
    Maggioni, Giulia
    Tentori, Cristina Astrid
    Bernardi, Massimo
    Di Grazia, Carmen
    Vago, Luca
    Rivoli, Giulia
    Borin, Lorenza
    D'Amico, Saverio
    Ubezio, Marta
    Campagna, Alessia
    Russo, Antonio
    Mannina, Daniele
    Lanino, Luca
    Chiusolo, Patrizia
    Giaccone, Luisa
    Voso, Maria Teresa
    Riva, Marta
    Oliva, Esther Natalie
    Zampini, Matteo
    Riva, Elena
    Nibourel, Olivier
    Sala, Claudia
    Bicchieri, Marilena
    Bolli, Niccolo
    Rambaldi, Alessandro
    Passamonti, Francesco
    Savevski, Victor
    Santoro, Armando
    Germing, Ulrich
    Kordasti, Shahram
    Santini, Valeria
    Diez-Campelo, Maria
    Sanz, Guillermo
    Sole, Francesc
    Kern, Wolfgang
    Platzbecker, Uwe
    Ades, Lionel
    Fenaux, Pierre
    Haferlach, Torsten
    Gastone, Castellani
    Della Porta, Matteo G.
    BLOOD, 2022, 140 : 1121 - 1124
  • [5] Assessment of the Molecular International Prognostic Scoring System (IPSS-M) Risk Stratification Model in Hypoplastic Myelodysplastic Syndromes
    Aguirre, Luis E.
    Al Ali, Najla
    Ball, Somedeb
    Singh, Avani M.
    Jain, Akriti G.
    Chan, Onyee
    Schwabkey, Zaker, I
    Tinsley-Vance, Sara M.
    Kuykendall, Andrew
    Sweet, Kendra
    Lancet, Jeffrey E.
    Padron, Eric
    Sallman, David A.
    Komrokji, Rami S.
    BLOOD, 2022, 140 : 6909 - 6911
  • [6] Assessment of the Molecular International Prognostic Scoring System (IPSS-M) Risk Stratification Model in TherapyRelated Myelodysplastic Syndromes
    Aguirre, Luis E.
    Al Ali, Najla
    Ball, Somedeb
    Singh, Avani M.
    Jain, Akriti G.
    Chan, Onyee
    Schwabkey, Zaker, I
    Tinsley-Vance, Sara M.
    Kuykendall, Andrew
    Sweet, Kendra
    Lancet, Jeffrey E.
    Padron, Eric
    Sallman, David A.
    Komrokji, Rami S.
    BLOOD, 2022, 140 : 9813 - 9815
  • [7] Early transfusion patterns improve the Molecular International Prognostic Scoring System (IPSS-M) prediction in myelodysplastic syndromes
    Creignou, Maria
    Bernard, Elsa
    Gasparini, Alessandro
    Tranberg, Anna
    Todisco, Gabriele
    Moura, Pedro Luis
    Ejerblad, Elisabeth
    Nilsson, Lars
    Garelius, Hege
    Antunovic, Petar
    Lorenz, Fryderyk
    Rasmussen, Bengt
    Walldin, Gunilla
    Mortera-Blanco, Teresa
    Jansson, Monika
    Tobiasson, Magnus
    Elena, Chiara
    Ferrari, Jacqueline
    Galli, Anna
    Pozzi, Sara
    Malcovati, Luca
    Edgren, Gustaf
    Crowther, Michael J.
    Jaedersten, Martin
    Papaemmanuil, Elli
    Hellstroem-Lindberg, Eva
    JOURNAL OF INTERNAL MEDICINE, 2024, 296 (01) : 53 - 67
  • [8] Comparison of the Molecular International Prognostic Scoring System (IPSS-M) and Revised International Prognostic Scoring System (IPSS-R) in predicting the prognosis of patients with myelodysplastic neoplasms treated with decitabine
    Nguyen, Quang Hao
    Vu, Minh Phuong
    Tran, Tuan Anh
    Duong, Quoc Chinh
    Vu, Duc Binh
    Nguyen, Ha Thanh
    Bach, Quoc Khanh
    ONCOLOGIE, 2024, 26 (02) : 323 - 328
  • [9] Performance of IPSS-M in patients with myelodysplastic syndrome after hypomethylating agent failure
    Urrutia, Samuel
    Chien, Kelly S. S.
    Li, Ziyi
    Bataller, Alex
    Almanza, Emmanuel
    Sasaki, Koji
    Montalban-Bravo, Guillermo
    Short, Nicholas J. J.
    Jabbour, Elias
    Kadia, Tapan M. M.
    Ravandi, Farhad
    Borthakur, Gautam
    Alvarado, Yesid
    Daver, Naval
    Kanagal-Shamanna, Rashmi
    Bueso-Ramos, Carlos
    Pierce, Sherry A. A.
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (10) : E281 - E284
  • [10] Evaluation of the Molecular International Prognostic Scoring System (IPSS-M) in Patients (Pts) with Myelodysplastic Syndromes/Neoplasms (MDS) with Missing Molecular Data
    Kewan, Tariq
    Bewersdorf, Jan Philipp
    Blaha, Ondrej
    Stahl, Maximilian
    Al Ali, Najla H.
    DeZern, Amy E.
    Sekeres, Mikkael A.
    Carraway, Hetty E.
    Desai, Pinkal
    Griffiths, Elizabeth A.
    Stein, Eytan M.
    Brunner, Andrew M.
    Amaya, Maria L.
    Zeidner, Joshua F.
    Savona, Michael R.
    Stempel, Jessica M.
    Chandhok, Namrata Sonia
    Logothetis, Constantine
    Cochran, Hunter
    Singh, Abhay
    Roboz, Gail J.
    Rolles, Benjamin
    Wang, Eunice S.
    Harris, Amyah C.
    Shallis, Rory M.
    Xie, Zhuoer
    Padron, Eric
    Sallman, David A.
    Maciejewski, Jaroslaw P.
    Della Porta, Matteo Giovanni
    Komrokji, Rami S.
    Zeidan, Amer M.
    BLOOD, 2023, 142